Shandong Obersen Biomedicine, Inc.

The Shandong Obersen Biomedicine Industry Limited was established in 2010. Its headquarters is located in Jenan, Shandong Province, and its legal representative, Sun Liji. The Oberson Group industry covers four major areas: microbiology, nutrition, Chinese pharmacology and cytology. Specialized in the development and production of prophylactic bacteria, enzyme formulations, medically nutritious foods, motorly nutritious foods, nutrient supplements, prophylactic fermentation, plant stem cells, animal stem cells and derivatives, and tailored to client needs. It is a high-technology consortium that combines scientific research, development, production and operation, with exclusive research and development institutions, production bases and production lines. The production of high-density, high-stability, high-activity, high-activity dry powder, special micro-capacitation packages, active beryllium research and production technologies, Chinese fermentation and enrichment distillation technologies, high-density and fungi fermentation technologies, and plant and animal stem cell culture technologies are available. The registered capital is $10 million.